G

Gritstone bio

D
GRTS
USD
0.0932
(16.9055%)
Market Closed
76,615.00
Volume
-0.86
EPS
-
Div Yield
-0.550459
P/E
76,121,298.19
Market Cap
Today
16.9055%
1 Week
34.243%
1 Month
28.874%
6 Months
-76.130%
12 Months
-52.956%
Year To Date
-68.407%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
AMN
-0.865
(-1.8487%)
USD
L
LH
-2.54
(-1.1184%)
USD
D
DGX
-0.37
(-0.238%)
USD
T
THMO
(%)
USD
Q
QDEL
-0.005
(-0.0108%)
USD
H
HOLX
0.64
(0.7831%)
USD
I
ICLR
-0.92
(-0.3046%)
USD
A
ALGN
4.18
(1.6515%)
USD
DHR
DHR
4.69
(1.7253%)
USD

Title:
Gritstone bio

Sector:
Healthcare
Industry:
Biotechnology
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.
Do you need help or have a question?
Contact Us